170 articles
Lotte Holdings, through its Healthcare & Biopharmaceutical Corporate Venture Capital (HB-CVC), has invested in Rakuten Medical, Inc., marking its eighth HB-CVC investment.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
A new method developed by the National Museum of Nature and Science successfully determined the structure of diverse phenolic compounds from trace samples of alpine plant flowers.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Vetanic, which promotes animal regenerative medicine using iPS cells, has formed a capital and business alliance with Sysmex and Kohjin Bio to accelerate its initiatives.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
Hartech Biosector is conducting trials in Hokkaido to reduce agricultural damage and roadkills caused by deer, using starfish-derived "marine saponin" and UV-reflective technology visible to deer.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
H.U. Group has received manufacturing and marketing approval for its cancer genomic profiling system, 'Fujinokuni HOPE OncoPanel'.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Euglena Co.'s President Izumo spoke at a commemorative lecture for Dr. Muhammad Yunus's visit to Japan, outlining a future industry vision with sustainable technology and 'Three Zeros'.
Euglena Co.'s President Izumo spoke at a commemorative lecture for Dr. Muhammad Yunus's visit to Japan, outlining a future industry vision with sustainable technology and 'Three Zeros'.
BioRelix has launched a new service in Bali, Indonesia, providing research-grade peptides with guaranteed purity (≥98%) verified by third-party Certificates of Analysis (CoA). Payments are limited to USDT or cash, with same-day cold-chain delivery available across Bali. Products are sold for research use only and do not require a prescription.
To resolve anxiety about misjudgments in DNA testing, seeDNA Genetic Medical Research Institute launched the "Second Opinion Campaign" on April 3, 2026. It introduces past misjudgment cases and appeals for the importance of reliable re-testing.
To resolve anxiety about misjudgments in DNA testing, seeDNA Genetic Medical Research Institute launched the "Second Opinion Campaign" on April 3, 2026. It introduces past misjudgment cases and appeals for the importance of reliable re-testing.
Shi Zai Biotechnology is a social enterprise specializing in the research and development of bovine colostrum products. Through its core product, "MyDaily Fountain of Life Bovine Colostrum," the company aims to support the health and livelihood of families while engaging in community activities such as a senior academy and shuttle bus services for a cancer hospital.
Taiwanese health food brand 'Medfullife Fountain of Life' has released 'The Complete Guide to Bovine Colostrum,' explaining its nutritional value and health benefits. It enhances information provision for health-conscious consumers by explaining ingredients that contribute to improved immunity, digestion, and metabolism.
BioRelix has launched a new service in Bali, Indonesia, providing research-grade peptides with guaranteed purity (≥98%) verified by third-party Certificates of Analysis (CoA). Payments are limited to USDT or cash, with same-day cold-chain delivery available across Bali. Products are sold for research use only and do not require a prescription.
Shi Zai Biotechnology is a social enterprise specializing in the research and development of bovine colostrum products. Through its core product, "MyDaily Fountain of Life Bovine Colostrum," the company aims to support the health and livelihood of families while engaging in community activities such as a senior academy and shuttle bus services for a cancer hospital.
Taiwanese health food brand 'Medfullife Fountain of Life' has released 'The Complete Guide to Bovine Colostrum,' explaining its nutritional value and health benefits. It enhances information provision for health-conscious consumers by explaining ingredients that contribute to improved immunity, digestion, and metabolism.